戻る
Repare Therapeutics Inc (RPTX)価格
RPTX 株価推移チャート
RPTX 財務
Repare Therapeutics Inc
$2.65
0.76%
$0.02
終値： Jan 27, 16:00:00 GMT-5
$2.64
-0.36%
$0
アフターマーケット：Jan 27, 20:00:00 GMT-5
主要データ
前終値
$2.63
始値
$2.64
当日レンジ
$2.62 - $2.65
52週レンジ
$0.89 - $2.66
取引高
1.1M
平均取引高
1.1M
1株当たり利益(TTM)
-1.69
配当利回り
--
時価総額
$113.5M
RPTXとは何ですか？
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company is headquartered in St-Laurent, Quebec and currently employs 129 full-time employees. The company went IPO on 2020-06-19. The firm utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes RP-3467, a Phase 1 Polo ATPase inhibitor; RP-1664, a Phase 1 PLK4 inhibitor, and lunresertib, a PKMYT1 inhibitor.